BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33751327)

  • 1. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.
    Ai X; Dong X; Guo Y; Yang P; Hou Y; Bai J; Zhang S; Wang X
    Purinergic Signal; 2021 Jun; 17(2):229-240. PubMed ID: 33751327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.
    Woo SH; Trinh TN
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP acting on P2Y receptors triggers calcium mobilization in Schwann cells at the neuroelectrocyte junction in skate.
    Green AC; Dowdall MJ; Richardson CM
    Neuroscience; 1997 Sep; 80(2):635-51. PubMed ID: 9284364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of basal forebrain purinergic P2 receptors promotes wakefulness in mice.
    Yang C; Larin A; McKenna JT; Jacobson KA; Winston S; Strecker RE; Kalinchuk A; Basheer R; Brown RE
    Sci Rep; 2018 Jul; 8(1):10730. PubMed ID: 30013200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
    Chiarella AM; Ryu YK; Manji GA; Rustgi AK
    Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular adenosine 5'-triphosphate in pulmonary disorders.
    Pelleg A
    Biochem Pharmacol; 2021 May; 187():114319. PubMed ID: 33161021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neary JT; McCarthy M; Kang Y; Zuniga S
    Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y1 receptor modulation of the pre-Bötzinger complex inspiratory rhythm generating network in vitro.
    Lorier AR; Huxtable AG; Robinson DM; Lipski J; Housley GD; Funk GD
    J Neurosci; 2007 Jan; 27(5):993-1005. PubMed ID: 17267553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of purinergic receptor subtypes modulates odor sensitivity.
    Hegg CC; Greenwood D; Huang W; Han P; Lucero MT
    J Neurosci; 2003 Sep; 23(23):8291-301. PubMed ID: 12967991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
    Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
    FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purinergic P2-receptors as potential targets of new pharmaceutical products].
    Ziganshin AU
    Vestn Ross Akad Med Nauk; 2011; (11):32-8. PubMed ID: 22312906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.
    Vartian N; Boehm S
    Eur J Neurosci; 2001 Mar; 13(5):899-908. PubMed ID: 11264662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase.
    Panenka W; Jijon H; Herx LM; Armstrong JN; Feighan D; Wei T; Yong VW; Ransohoff RM; MacVicar BA
    J Neurosci; 2001 Sep; 21(18):7135-42. PubMed ID: 11549724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide signalling during inflammation.
    Idzko M; Ferrari D; Eltzschig HK
    Nature; 2014 May; 509(7500):310-7. PubMed ID: 24828189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic targets for ATP-gated P2X receptor ion channels.
    Li Z; Liang D; Chen L
    Assay Drug Dev Technol; 2008 Apr; 6(2):277-84. PubMed ID: 18471080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling by ATP receptors in astrocytes.
    Neary JT; Zhu Q
    Neuroreport; 1994 Aug; 5(13):1617-20. PubMed ID: 7819532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.